Colloidal semiconductor nanocrystals are widely used as lumiphores in biological imaging because their luminescence is both strong and stable, and because they can be biofunctionalized. During synthesis, nanocrystals are typically passivated with hydrophobic organic ligands 1 , so it is then necessary either to replace these ligands or encapsulate the nanocrystals with hydrophilic moieties to make the lumiphores soluble in water. Finally, biological labels must be added to allow the detection of nucleic acids, proteins and specific cell types 2-8 . This multistep process is time-and labour-intensive and thus out of reach of many researchers who want to use luminescent nanocrystals as customized lumiphores. Here, we show that a single designer ligand-a chimeric DNA molecule -can controllably program both the growth and the biofunctionalization of the nanocrystals. One part of the DNA sequence controls the nanocrystal passivation and serves as a ligand, while another part controls the biorecognition. The synthetic protocol reported here is straightforward and produces a homogeneous dispersion of nanocrystal lumiphores functionalized with a single biomolecular receptor. The nanocrystals exhibit strong optical emission in the visible region, minimal toxicity and have hydrodynamic diameters of ∼6 nm, which makes them suitable for bioimaging 4 . We show that the nanocrystals can specifically bind DNA, proteins or cells that have unique surface recognition markers.DNA is well suited to the task of producing customized nanocrystal lumiphores because it is known to serve as a receptor for molecular recognition 9 and as an inert nanocrystal passivator 10-15 . Both nucleic acids sequence and structure have been used to control the properties of lead-and cadmium-containing nanocrystals 13,14 , and the materials made in this way have been shown to have low cellular toxicity and good properties for cellular imaging 13 . However, little has been done to functionalize these materials to enable versatile molecular recognition. An aptamer-based strategy using DNA for both nanoparticle liganding during growth and protein detection has recently been reported 15 ; the toxicities and hydrodynamic radii of these materials were not investigated, and although the proposed
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript application of the strategy was restricted to a single protein, adsorption of non-target proteins was noted. In summary, although promising advances have already been made, a general approach to high-fidelity biomolecular functionalization of nanocrystals capable of specifically binding to a diverse range of targets has never previously been explored.We designed a one-pot synthesis that would allow nucleic acids-functionalized nanocrystals to be prepared that would bind a variety of biomolecular targets. The approach relies on the design of chimeric oligonucleotides that contain two different domains-one that will be liganded to the nanocrystal, and one that will be capable of molecular ...